EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHOEA‐PREDOMINANT IRRITABLE BOWEL SYNDROME: A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO‐CONTROLLED TRIALS

Brian Lacy  1     Mark Pimentel  2     Christopher Chang  3     Zeev Heimanson  4     Anthony J. Lembo  5    
1 Mayo Clinic Hospital,Jacksonville,United States
2 Cedars-Sinai Medical Center,Los Angeles,United States
3 New Mexico VA Health Care System,Albuquerque,United States
4 Salix Pharmaceuticals,Bridgewater,United States
5 Beth Israel Deaconess Medical Center,Boston,United States

Session
IBS II

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing